Western Wealth Management’s First Trust Indxx NextG ETF NXTG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$209K Sell
1,360
-15
-1% -$2.27K 0.01% 905
2026
Q2
$211K Buy
+1,375
New +$196K 0.01% 954
2024
Q4
– Sell
-2,418
Closed -$211K – 779
2024
Q3
$211K Buy
+2,418
New +$203K 0.01% 704
2022
Q4
– Sell
-5,997
Closed -$337K – 744
2022
Q3
$337K Buy
5,997
+112
+2% +$7.18K 0.02% 598
2022
Q2
$377K Sell
5,885
-9,824
-63% -$685K 0.02% 545
2022
Q1
$1.19M Buy
15,709
+6,805
+76% +$523K 0.06% 307
2021
Q4
$735K Buy
+8,904
New +$709K 0.07% 253
2021
Q2
$641K Buy
8,402
+274
+3% +$20.5K 0.07% 305
2021
Q1
$594K Buy
8,128
+471
+6% +$34.1K 0.08% 249
2020
Q4
$530K Buy
7,657
+352
+5% +$22.5K 0.08% 241
2020
Q3
$433K Buy
+7,305
New +$428K 0.07% 263

Other funds holding NXTG

Western Wealth Management's NXTG Position: Q3 2026 in Review

Western Wealth Management reduced its First Trust Indxx NextG ETF (NXTG) stake by 1.1% in Q3 2026, selling an estimated $2.27K and leaving 1,360 shares worth $209K. The position accounts for 0.01% of the portfolio, ranked #905.

Western Wealth Management first reported a position in NXTG in Q3 2020 and has held it in 11 quarters since. The position peaked at $1.19M in Q1 2022. 91 funds tracked by Wall St. Rank hold NXTG as of Q3 2026.

  • Western Wealth Management held 1,360 shares of First Trust Indxx NextG ETF worth $209K as of Q3 2026.
  • Western Wealth Management sold 15 First Trust Indxx NextG ETF shares in Q3 2026, an estimated $2.27K.
  • First Trust Indxx NextG ETF made up 0.01% of Western Wealth Management's portfolio in Q3 2026, its #905 holding.
  • Western Wealth Management first reported a position in First Trust Indxx NextG ETF in Q3 2020 and has held it in 11 quarters since.
  • Western Wealth Management's First Trust Indxx NextG ETF position peaked at $1.19M in Q1 2022.
  • 91 funds tracked by Wall St. Rank held First Trust Indxx NextG ETF as of Q3 2026.

Based on Western Wealth Management's 13F filing for Q3 2026, filed 9 Nov 2026.